Novavax Posts Good Covid Vaccine Data; Sanofi, GlaxoSmithKline Start First Human TestsInvestors Business Daily • 09/03/20
Sanofi, GSK Start Early-Stage Clinical Trials Of Jointly-Developed COVID-19 VaccineBenzinga • 09/03/20
Sanofi and GSK initiate Phase 1/2 clinical trial of COVID-19 adjuvanted recombinant protein-based vaccine candidateGlobeNewsWire • 09/03/20
COVID-19 Update: Gottlieb On Vaccine Approval Timeline, GSK Exec Talks Antibody DrugBenzinga • 08/31/20
GlaxoSmithKline and partner Vir join the race to find a coronavirus antibody treatmentCNBC • 08/31/20
Vir Biotechnology and GSK Start Phase 2/3 Study of COVID-19 Antibody TreatmentGlobeNewsWire • 08/31/20
GlaxoSmithKline: Quality 5% Dividend Yield Backed By Diversified Asset PortfolioSeeking Alpha • 08/21/20
These 4 Drugmakers Are Using AI to Improve Their Products. Does It Make Them Better Buys?The Motley Fool • 08/15/20
The U.S. has already invested billions on potential coronavirus vaccines. Here's where the deals standCNBC • 08/14/20
FDA Approves GSK’s BLENREP (belantamab mafodotin-blmf) for the Treatment of Patients with Relapsed or Refractory Multiple MyelomaBusiness Wire • 08/06/20